Evidence map›Paper›PMID 41262108›Full record

ArticleInternational journal of developmental disabilities2025

Comparison of HMGB1, RAGE, TLR4, and NF-κB levels in children and adolescents diagnosed with autism spectrum disorder with healthy controls.

Esra Kıyat, Evrim Aktepe, Duygu Kumbul Doğuç, Mehmet Bedir, Emre Ertürk, Ümit Işık

Abstract read
In one paragraph

Article in International journal of developmental disabilities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Esra KıyatDepartment of Child and Adolescent Psychiatry, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.
Evrim AktepeDepartment of Child and Adolescent Psychiatry, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.ORCID https://orcid.org/0000-0002-3082-4428
Duygu Kumbul DoğuçDepartment of Biochemistry, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.
Mehmet BedirDepartment of Biochemistry, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.
Emre ErtürkDepartment of Child and Adolescent Psychiatry, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.ORCID https://orcid.org/0000-0001-8116-0222
Ümit IşıkDepartment of Child and Adolescent Psychiatry, Private Practice, Isparta, Turkey.ORCID https://orcid.org/0000-0001-6006-3247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The objective of our study is to clarify the involvement of the HMGB1/RAGE/TLR4/NF-kB axis, a crucial component in inflammation, in the etiopathogenesis of autism spectrum disorder (ASD). Method: We analyzed the levels of HMGB1, RAGE, TLR4, and NF-kB in serum from 80 children (40 with ASD and 40 controls). All participants' sociodemographic characteristics were recorded. In order to determine the severity of the disorder, the Aberrant Behavior Checklist, Childhood Autism Rating Scale, and Autism Behavior Checklist were administered to the ASD group. Result: While the soluble TLR4 level was significantly higher in the ASD group ( Discussion: It was thought that serum TLR4 levels may be important in the etiology of ASD. TLR4 levels are linked to symptoms like hyperactivity in autism, which suggests that this parameter could be used as a clinical guide. Further research is required to substantiate our discoveries and to clarify the involvement of HMGB1, RAGE, TLR4, and NF-kB in the etiopathogenesis of ASD.

Indexed as

autism spectrum disorderHMGB1NF-kBRAGETLR4

Identifiers

PMID41262108
PMCPMC12624962

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.